GeneralConnection.com ➔ Dictionary
Dictionary Search

infliximab

Synonyms

Noun

1. Remicade

2. anti-TNF compound

Usage
Effectiveness of Infliximab for Refractory Nonischemic Cerebral Enhancing Foreign-Body Granulomatous Lesions After Endovascular Therapy - Neurology® Journals
Early Colectomy After Infliximab in Ulcerative Colitis Linked to C. difficile Infection - Docwire News
Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn’s disease - Nature
The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance - The American Journal of Managed Care® (AJMC®)
Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD - Wiley
Melkersson-Rosenthal Syndrome: A Case Treated With Infliximab - Cureus
Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal - PR Newswire
Celltrion Launches IV Formulation of Biosimilar Infliximab in Europe - Pearce IP
Celltrion launches liquid formulation of Remsima IV in Europe to strengthen infliximab market leadership - koreabiomed.com
Australian Patients With IBD Switched to Biosimilar Infliximab Maintain Long-Term Persistence - Center for Biosimilars
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD - Pharmacy Times
Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease - Frontiers
‘Pleasantly surprised’: Subcutaneous infliximab effective, regardless of Crohn’s location - Healio
Corticosteroid Premedication for Infliximab Remains Unnecessarily Common - The American Journal of Managed Care® (AJMC®)
Secondary Hemophagocytic Lymphohistiocytosis in a Patient With Crohn’s Disease Receiving Infliximab: A Diagnostic Challenge - Cureus
Association of the TNFRSF1B -rs1061622 variant with nonresponse to infliximab in ulcerative colitis - Nature
Study Shows Infliximab Biosimilar is Safe in Patients Undergoing RA Treatment - Pharmacy Times
Celltrion Secures First Approval of Infliximab IV Liquid Formulation - Pearce IP
Higher induction and maintenance infliximab trough levels are associated with radiological perianal fistula healing in pediatric patients with Crohn's disease - Frontiers
Fulminant Tuberculous Pericarditis Presenting as Cardiac Tamponade in an Infliximab-Treated Patient - Cureus
Infliximab-Induced Autoimmune Phenomenon in an Adolescent With Ulcerative Colitis: Drug-Induced Lupus vs Inflammatory Myositis - Cureus
Implications of the First Liquid IV Infliximab Biosimilar - BioPharm International
Danish Registry Analysis Finds Consistent Safety After Switching to Infliximab Biosimilar GP1111 - Center for Biosimilars
Accelerated infliximab induction reduces long-term odds of colectomy in ulcerative colitis - Healio
New ECCO data show subcutaneous (SC) infliximab (Remsima SC) effectively recaptures and maintains disease control after drug holiday - Business Wire
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab - Business Wire
Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions - Business Wire
Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients - Frontiers
Case Report: Infliximab for hydroxychloroquine-induced AGEP with IL17A and IL36RN mutations: a case report and management considerations - Frontiers
Refractory Kawasaki Disease With a Coronary Artery Aneurysm in a Three-Month-Old Infant: Diagnostic Challenges and Rescue With Infliximab - Cureus
Precision-Medicine Approach Improves IBD Infliximab Outcomes - Medscape
Celltrion's Zymfentra U.S. Prescriptions Triple in January - thelec.net
Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds - Pharmacy Times
PET/CT supports use of infliximab for cardiac sarcoidosis - AuntMinnie
Successful Treatment of Pediatric Neurosarcoidosis With Corticosteroids, Infliximab, and Methotrexate - ScienceDirect.com
Infliximab treatment for autoimmune hepatitis - Clínica FEHV
Pfizer’s IV Infliximab Biosimilar Approved in NZ - Pearce IP
Infliximab-Induced Vasculitis in a Rheumatoid Arthritis Patient: A Comprehensive Case Report - Cureus
Infliximab-Induced Pulmonary Sarcoidosis Treated With Upadacitinib: A Case Report and Review of the Literature - Cureus
Who should be treated with infliximab during a severe Colitis flare-up? - Crohn's & Colitis UK
Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy - Wiley Online Library
Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease - NEJM Evidence
Additional Dose of IVIG Provides Positive Therapeutic Effect in Patients With Infliximab-Refractory Kawasaki Disease - Pharmacy Times
Celltrion’s Remsima cements status as S.Korea’s blockbuster global medicine - The Korea Economic Daily Global Edition
Oxford patients with sarcoidosis in lungs given new drug - BBC
Increasing Biosimilar Use Reflects Changing Practice in Pediatric IBD Care - Center for Biosimilars
Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome - NEJM Evidence
Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis - Frontiers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis - The New England Journal of Medicine
Zymfentra, a Subcutaneous Formulation of Infliximab, Approved for IBD - Medical Professionals Reference
Effectiveness of switching to subcutaneous infliximab in inflammatory bowel disease patients with inadequate biochemical response during intravenous administration - Nature
Celltrion Launches Trastuzumab and Infliximab Biosimilars in Vietnam - Pearce IP
FDA Approves First Subcutaneous Infliximab Product - Center for Biosimilars
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials - The Lancet
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease - The New England Journal of Medicine
Celltrion’s Zymfentra chalks up fast growth in US - The Korea News Plus
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis - Nature
Biosimilars of infliximab - Generics and Biosimilars Initiative
Infliximab treatment in pathology-confirmed neurosarcoidosis - Neurology® Journals
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial - The Lancet
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease - The New England Journal of Medicine
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome - Nature
Are Live Vaccines Safe for Infants Exposed to Infliximab During Parent’s IBD Treatment? - Gastroenterology Advisor
ZYMFENTRA™(infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab, now commercially available in the U.S. - PR Newswire
Weight Gain on Infliximab Tied to Sex, Crohn Disease, and Disease Severity - Gastroenterology Advisor
Opacity over live vaccines in infants exposed to infliximab - The Lancet
Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease - Frontiers
Aggressive Infliximab Dosing Shows No Added Benefit in Acute Severe Ulcerative Colitis - Medscape
Infliximab Cost - News-Medical
An interspecies translation model implicates integrin signaling in infliximab-resistant inflammatory bowel disease - Science | AAAS
The first WHO reference panel for Infliximab anti-drug antibodies: a step towards harmonizing therapeutic drug monitoring - Frontiers
Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching - Nature
Treating IBD During Pregnancy - Johns Hopkins Medicine
Aberdeen ‘lifeline’ for young people with IBD - HealthandCare.scot
Phase 3 Trials Find Subcutaneous Infliximab CT-P13 Superior to Placebo in IBD - Center for Biosimilars
The impact of medication belief on adherence to infliximab in patients with Crohn’s disease - Frontiers
Celltrion launches Remsima IV liquid formulation in Europe, targeting global infliximab market leadership - 더바이오
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome - Nature
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent - The New England Journal of Medicine
Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile - Nature
Infliximab is a plausible alternative for neurologic complications of Behçet disease - Neurology® Journals
Initial dose of infliximab 5 mg/kg ‘should be adequate’ in most cases of acute severe UC - Healio
Early Crohn's treatment 'could save NHS millions' - BBC
Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system - Nature
Vedolizumab Beats Infliximab as Second-Line Therapy for Ulcerative Colitis - Medscape
Timing of Infliximab Infusion Prior to Surgery and Post-Operative Infections - Rheumatology Advisor
Case Report: Hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis - Frontiers
Lack of Interchangeable Biosimilars Keeps J&J in the Infliximab Game - BioProcess International
Posters Demonstrate Switching Safety Between Originator, Biosimilar Infliximab in IBD - Center for Biosimilars
Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report - Frontiers
Infliximab Biosimilar CT-P13 Provides Consistent Safety, Efficacy Across 4 Diseases - HCPLive
Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy - Frontiers
Intravenous to Subcutaneous Infliximab Switch Shows Promise in IBD Management - Medscape
Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis - Wiley Online Library
Infliximab treatment in pathology-confirmed neurosarcoidosis - Neurology® Journals
The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China - Frontiers
Subcutaneous Infliximab Therapy Efficacious for Inflammatory Bowel Disease - Gastroenterology Advisor
Comparable Pregnancy and Infant Milestones With Infliximab Biosimilars vs Originator in IBD - Center for Biosimilars
Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival - Nature
Infliximab bests cyclophosphamide as first-line treatment of severe Behçet’s syndrome - Healio
Foreign Language Equivalents
Foreign Language Equivalents of 'infliximab'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
ifnliximab,   nifliximab,   unfliximab,   inflixiab,   nfliximab,   infliximav,   inflliximab,   indliximab,   inflixomab,   inflximab,   inflxiimab,   infilximab,   ibfliximab,   onfliximab,   imfliximab,   infkiximab,   inflixiimab,   ifliximab,   infliximba,   infliximabb,   inflixumab,   inflixmiab,   infliixmab,   inflixinab,   inflixmab,   infliximaab,   inflixiamb,   infiximab,   ingliximab,   infloximab,   inflizimab,   iinfliximab,   inliximab,   infliiximab,   inflixi,ab,   influximab,   infliimab,   inffliximab,   inflixima,   infliximmab,   innfliximab,   infliximsb,   inlfiximab,   infliximb,   inf;iximab,   infliximan,   inflicimab,   inflixximab
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z